Publication | Open Access
<scp>AQW</scp>051, a novel, potent and selective<scp>α</scp>7 nicotinic<scp>ACh</scp>receptor partial agonist: pharmacological characterization and phase<scp>I</scp>evaluation
32
Citations
34
References
2014
Year
These data support further development of AQW051 as a cognitive-enhancing agent, as a therapeutic, for example, in Alzheimer's disease or schizophrenia.
| Year | Citations | |
|---|---|---|
Page 1
Page 1